On the other way, aPVAT-residing adipocytes could release leptin and fatty acid-binding protein 4 (FABP4) to promote IL-18 targeting to macrophages, VSMCs, and ECs in mouse with AAA (Liu et al., 2020). This evidence concerns the gene FABP4 and triple-A syndrome.